JAGSONPAL PHARMACEUTICALS
JAGSNPHARM · NSE
221.94
-9.02 (-3.91%)
as of 29 Oct 2026 close
Open
219.52
High
231.81
Low
211.00
Prev close
230.96
52w high
264.50
30 Jun 2026
52w low
155.00
22 Jan 2026
VWAP
220.28
Delivery %
26.1%
of volume
Volume 2.49 L · turnover ₹5.49 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 04 Jan 2010
- ISIN
- INE048B01035
- Series
- EQ
- Listed on NSE
- 01 Mar 2000
- Face value
- ₹2
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Moving averages & momentum · as of 29 Oct 2026 close
| SMA 20 | 224.60 |
| SMA 50 | 231.07 |
| SMA 200 | 207.80 |
| RSI 14 | 46.6 |
| ATR 14 | 10.71 |
How these are computed
SMA n = mean of last n daily closes. RSI 14 = Wilder smoothing of average gains/losses over 14 days. ATR 14 = Wilder average of true range (max of high−low, |high−prev close|, |low−prev close|). All from NSE end-of-day candles; nothing intraday.
52-week position · as of 29 Oct 2026 close
155.00 22 Jan 202661% of range264.50 30 Jun 2026
Returns · close to close
1w
+5.25%
1m
-7.92%
3m
-3.71%
6m
+7.97%
1y
+2.95%
Corporate actions · latest 12 · NSE
| 04 Sept 2026 | Dividend | ₹4/share |
| 04 May 2026 | Buyback | |
| 12 Sept 2025 | Dividend | ₹2.5/share |
| 08 Jan 2025 | Price adjustment | ×2.517 |
| 08 Jan 2025 | Split | ×2.5 |
| 06 Sept 2024 | Dividend | ₹5/share |
| 21 Aug 2023 | Dividend | ₹5/share |
| 29 Oct 2021 | Dividend | ₹4/share |
| 22 Sept 2021 | Dividend | ₹1/share |
| 22 Sept 2020 | Dividend | ₹0.5/share |
| 20 Sept 2019 | Dividend | ₹0.25/share |
| 18 Sept 2018 | Dividend | ₹0.1/share |
Ex-dates and subjects from NSE's corporate-actions feed; price-adjustment factors checked against the exchange's own prices. Charts use the adjusted series by default.